FORWARD GLOBAL
FORWARD GLOBAL filed a registration for QUOIN PHARMACEUTICALS, INC. on April 21, 2025.
Lobbying for QUOIN PHARMACEUTICALS, INC. · Development and commercialization of therapeutic drug products that treat rare diseases.
-
NOE GARCIA III New on this filingPreviously held: Senior Policy Advisor, Senate Majority Leader, Bill Frist; Associate Political Director, The White House; Senior Advisor, Public Affairs, US Treasury Department; Public Liaison, US Treasury Department; Legislative Assistant, Rep. Kay Hutchison
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.